2 models fit ACRES Commercial Realty Corp. Common Stock and they disagree: 0 of 2 land within 15% of the average.
Two or more of our models back this value.
Large discount(i)
Valued as a REIT (property company): Price to FFO, Dividend discount, and EV/EBITDA comparison.
ACCE opinionACRES Commercial Realty Corp. Common Stock (ACR)
Fair value (2 models)
$18.07
ACCE price target
$10.10
Rating
Undervalued
Horizon
12 months
Fair value published on 24 Oct 2026, 17:04 CEST; previously $17.48 since 17 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 24 Oct 2026, 17:04 CEST.
Price used: $11.69 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount and Price to FFO.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
35.3% below
+54.6% to fair value
ACCE score
37
out of 100
Analysts
33% buy
3 covering
1-year return
-39.3%
Dividend yield
0.00%
ACRES Commercial Realty Corp. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
ACRES Commercial Realty (ACR) is a small mortgage REIT that originates and holds commercial real estate loans, mostly floating-rate bridge and transitional loans on multifamily and other income-producing properties, with a market capitalization of about $163M. The case for a closer look rests on a forward P/E of 10.6 against a trailing P/E of zero, which suggests earnings are expected to recover after a difficult stretch, and an ROE of 5.5% that is positive but thin. Revenue fell 14.8% and the operating margin is slightly negative at -2.2%, so the recovery is still an assumption rather than something the reported numbers show yet. The stock carries a 37/100 score and has no index membership, which is consistent with a name the market has not yet warmed to. The question for the deeper work is whether the loan book's credit quality and net interest spread can stabilize as the rate environment shifts.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Leverage and thin cash flow
Debt/Equity is 3.78 and free cash flow is only $4M against a $163M market cap, so the balance sheet leaves little room if credit conditions tighten.
moderate
Revenue shrinking
Revenue fell 14.8% year over year, while the 5-year revenue CAGR is just 2.1%. The earnings jump of 272.2% does not offset a top line in decline.
moderate
Operating margin negative
Operating margin is -2.2% even though net margin is +16.6%, so reported profit leans on items below the operating line rather than core operations.
moderate
Score down over 90 days
The ACCE score dropped 8 points from 46 to 38 over 90 days, with Momentum at 17 the weakest component.
AI research notes
AI-assisted·How I use AIWritten Oct 18, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Analysts' mean price target of $23.00 sits well above the current share price, suggesting some on the Street see substantial upside.
The consensus model fair value of $18.07 sits 35.3% above where the stock trades, which many value-minded investors would find appealing.
Free cash flow of $4M over the last twelve months and a 2.4% free cash flow yield show the business still generates cash for shareholders.
Why it could disappoint
Revenue fell 14.8% year over year, a sharp reversal against a five-year average of growth of 2.1% per year.
Debt to equity of 3.78 means the company carries heavy borrowing relative to its equity, leaving little cushion if earnings weaken.
Return on invested capital of 0.9% is very thin, and the latest earnings per share surprise came in at -7633.3%, with EPS of -2.26 against 0.03 expected.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where ACR's valuation models land
Price
$11.69
Model fair value
$18.07
Model range
$3.17 to $30.49
Fair value $18.07
Price $11.69
The price sits inside the model range.
Model
Fair value
Upside
Dividend discount
EV/EBITDA comparison
Price to FFO
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores